Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy

Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.

Detalles Bibliográficos
Autores principales: Carver, Alicia B, Zuckerman, Autumn D, DeClercq, Joshua, Choi, Leena, Chastain, Cody A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770330/
https://www.ncbi.nlm.nih.gov/pubmed/33409333
http://dx.doi.org/10.1093/ofid/ofaa569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770330/
https://www.ncbi.nlm.nih.gov/pubmed/33409333
http://dx.doi.org/10.1093/ofid/ofaa569

Ejemplares similares